Disease severity dictates SARS-CoV-2-specific neutralizing antibody responses in COVID-19 - PubMed (original) (raw)

SARS-CoV-2 antibody magnitude and detectability are driven by disease severity, timing, and assay.

Peluso MJ, Takahashi S, Hakim J, Kelly JD, Torres L, Iyer NS, Turcios K, Janson O, Munter SE, Thanh C, Nixon CC, Hoh R, Tai V, Fehrman EA, Hernandez Y, Spinelli MA, Gandhi M, Palafox MA, Vallari A, Rodgers MA, Prostko J, Hackett J Jr, Trinh L, Wrin T, Petroplolous CJ, Chiu CY, Norris PJ, DiGermanio C, Stone M, Busch MP, Elledge SK, Zhou XX, Wells JA, Shu A, Kurtz TW, Pak JE, Wu W, Burbelo PD, Cohen JI, Rutishauser RL, Martin JN, Deeks SG, Henrich TJ, Rodriguez-Barraquer I, Greenhouse B. Peluso MJ, et al. medRxiv [Preprint]. 2021 Mar 5:2021.03.03.21251639. doi: 10.1101/2021.03.03.21251639. medRxiv. 2021. PMID: 33688675 Free PMC article. Updated. Preprint.

Natural killer cell-mediated ADCC in SARS-CoV-2-infected individuals and vaccine recipients.

Hagemann K, Riecken K, Jung JM, Hildebrandt H, Menzel S, Bunders MJ, Fehse B, Koch-Nolte F, Heinrich F, Peine S, Schulze Zur Wiesch J, Brehm TT, Addo MM, Lütgehetmann M, Altfeld M. Hagemann K, et al. Eur J Immunol. 2022 Aug;52(8):1297-1307. doi: 10.1002/eji.202149470. Epub 2022 Apr 22. Eur J Immunol. 2022. PMID: 35416291 Free PMC article.

Exposure to avian coronavirus vaccines is associated with increased levels of SARS-CoV-2-cross-reactive antibodies.

Ardicli O, Carli KT, Satitsuksanoa P, Dreher A, Cusini A, Hutter S, Mirer D, Rückert B, Jonsdottir HR, Weber B, Cervia C, Akdis M, Boyman O, Eggel A, Brüggen MC, Akdis CA, van de Veen W. Ardicli O, et al. Allergy. 2022 Dec;77(12):3648-3662. doi: 10.1111/all.15441. Epub 2022 Jul 23. Allergy. 2022. PMID: 35869837 Free PMC article.